- GoodRx expects to revise six-month EPS to 7 cents.
- The prior six-month EPS figure was 3 cents.
GoodRx said it expects to revise its six-month earnings per share to 7 cents from 3 cents. The company did not detail the period covered, the reason for the change, or the basis of the measure. The revised figure is more than double the prior number.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.